Patient ‘organoids’ may predict chemotherapy effects
By GREGORY ZELLER // Unique cancer treatments, customized to specific patients, may be on the way. Among the things making cancer so vexing are the many physiological variables in play,…
Cold Spring Harbor Laboratory
With $10M start, SBU to lead LI biomedical network
By GREGORY ZELLER // Long Island biomedicine is about to be remade, with Stony Brook University leading the way. The flagship State University of New York institution has been selected…
Old friend takes the reins as Accelerate LI retools
By GREGORY ZELLER // From the Can’t Keep a Good Commercialization Organization Down file comes Accelerate Long Island, which is charging forward with new leadership and a new business-building mission….
Beefing up cancer treatments, with a vaccine in sight
By GREGORY ZELLER // New vaccines produced in part by a progressive Long Island biotech could significantly increase the efficacy of existing cancer treatments. The potential breakthrough – detailed this…
Study: Enjoy those nachos and beat COVID, too
By GREGORY ZELLER // High doses of an over-the-counter antacid can reduce the severity of COVID-19 symptoms. The important news about the common heartburn drug famotidine – known best by…
No. 664: La-Z-Boys, lattes and stressed-out CEOS – with birthday wishes for America’s greatest inventor
Ad nauseum: We’ve said it before and we’ll say it again, intrepid innovator – you’ve conquered another workweek and queued up another weekend, and we don’t know how you…
For Broad Hollow Bioscience Park, a beauty of a deal
By GREGORY ZELLER // A major-league anchor tenant will breathe new life into Broad Hollow Bioscience Park. The not-for-profit facility on the Farmingdale State College campus, designed primarily to support…
Albany pumps $40M into biotech commercialization
By GREGORY ZELLER // Good news for Long Island’s impressive biotech-research corridor: New York State has opened a new Biodefense Commercialization Fund designed to speed promising life-science research to market….
New collaboration gives Acupath wings, literally
By GREGORY ZELLER // Despite the lingering threat of COVID-19, Acupath has announced a world tour. Actually, the tour is because of that lingering threat. Acupath Laboratories, the Plainview-based diagnostics…
Small screen, big honor for Emmy-nominated series
By GREGORY ZELLER // And the Emmy Award nominations go to … HJMT Public Relations! Whether the Long Beach-based PR house walks away with a golden statuette remains to be…
No. 594: The masks come off, biotech pioneers unite and the circus comes to town (plus, chocolate cake!)
You’re getting warmer, comrade: Welcome to Wednesday, dear readers, as we work our way through this – dare we say “summerlike?” – week of socioeconomic innovation. It’s May 19…
New collaboration cuts to the heart of RNA splicing
By GREGORY ZELLER // A Cold Spring Harbor Laboratory spinoff and a Massachusetts-based neuroscience trailblazer are teaming up to advance ribonucleic acid splicing research – key to addressing several central…
Innovation in the Age of Coronavirus
Vaccinations are ramping up and the pandemic is winding down, but COVID-19 continues to reshape the world around us. And myriad Long Island forces – large and small, corporate and…
Large buy-in has DepYmed eyeing huge clinical trials
By GREGORY ZELLER // Farmingdale pharmaceutical firm DepYmed is no stranger to capital investments – but a new infusion might be enough to push the rare-disease innovator over the commercialization…
No. 558: It’s a riot – filled with Darwinians, smooth moves and tiny bubbles
So, how was your week? Sanity reigns, the Republic stands and the business of innovation carries on – and so does Innovate LI, despite a bellyful of website and…